AffiNANOTECH® MC-VC-PABC-amide-PEG1-CH2-CC-885

Availables Sizes: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Overview

MC-VC-PABC-amide-PEG1-CH2-CC-885 (compound III) is a neoDegrader, a conjugate of the GSPT1 degrader/molecular glueCC-885 (HY-101488) and a linker. MC-VC-PABC-amide-PEG1-CH2-CC-885 can be conjugated to the antibody DAR3.7 that specifically targets CD56 to synthesizeAntibody-Drug Conjugates (ADCs) . MC-VC-PABC-amide-PEG1-CH2-CC-885 can also be conjugated toBelantamab (HY-P9980), Daratumumab (HY-P9915), huMy9-6IgG1, Indatuximab (HY-P990607), Isatuximab (HY-P9976), lintuzumabIgG1, Pertuzumab (HY-P9912), OR000213, Rituximab (HY-P9913), Sacituzumab (HY-P99045), Trastuzumab (HY-P9907) andU3-1784 (HY-P990672) to form conjugates.